Antibody Levels After COVID-19 Vaccination Inversely Linked to Body Weight

MONDAY, May 23, 2022 (HealthDay News) -- Following COVID-19 vaccination, there is an inverse correlation between anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific antibody levels and body weight, according to a study published online May 19 in JAMA Network Open.
Su Youn Nam, M.D., Ph.D., from Kyungpook National University Hospital in Daegu, South Korea, and colleagues examined factors associated with anti-SARS-CoV-2 antibody levels in a prospective cohort study involving 50 health care workers with no history of SARS-CoV-2 infection who received two doses of the BNT162b2 mRNA COVID-19 vaccine (first dose, March 17 to 21, 2021; second dose, April 7 to 10, 2021).
The researchers found that over time, the mean serum antibody level decreased (91.9, 89.3, and 81.5 percent at two, four, and six months, respectively). There was a correlation for serum antibody levels at six months with antibody levels at two months. An inverse correlation was seen for the anti-SARS-CoV-2-specific antibody level with weight, body mass index (BMI), body fat amount, and body weight-to-height ratio. In a multiple linear regression analysis for women, a one-standard deviation (SD) increase in body weight, weight-to-height ratio, and BMI was associated with a 4 to 5 percent decrease in anti-SARS-CoV-2 antibodies. A lower serum level of antibody (<81.5 percent) was associated with weight in an adjusted analysis using categorized variables (weight ≥55 kg: odds ratio, 9.01).
"Anti-SARS-CoV-2 antibody levels at two, four, and six months after vaccination were inversely correlated with weight, BMI, and weight-to-height ratio. Further studies are needed to clarify these findings," the authors write.
The study was supported by SG Medical 2021.
Related Posts
La vacuna contra la COVID de tres dosis de Pfizer provoca una fuerte respuesta en los niños más pequeños
LUNES, 23 de mayo de 2022 (HealthDay News) -- Pfizer/BioNTech afirma que un...
Most Pivotal Trials of New Drugs Recruit From Low-, Middle-Income Countries
MONDAY, Nov. 21, 2022 (HealthDay News) -- Most pivotal trials of new cancer,...
FDA Allows Pharmacists to Prescribe COVID-19 Drug Paxlovid
THURSDAY, July 7, 2022 (HealthDay News) -- Patients who test positive for...
Johnson & Johnson acepta un acuerdo de 8.9 mil millones de dólares en unas demandas por el polvo de talco
MIÉRCOLES, 5 de abril de 2023 (HealthDay News) -- Decenas de miles de personas...